Domitroban 

多米曲班

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDomitroban 
Drug Alias NameAnboxanS-1452
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 receptor antagonists
TargetsThromboxane A2 receptor
Therapy Area/IndicationsThrombosisThromboembolismCoronary Thrombosis +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShionogi & Co Ltd
Active IndicationsN/A
Inactive IndicationsThrombosisThromboembolismCoronary Thrombosis +[5

Other Information

ATC CodeN/A
Related LinksN/A